1. Home
  2. ASMB vs NPCE Comparison

ASMB vs NPCE Comparison

Compare ASMB & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$35.44

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$14.85

Market Cap

490.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
NPCE
Founded
2005
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
490.2M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
ASMB
NPCE
Price
$35.44
$14.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$44.20
$18.33
AVG Volume (30 Days)
289.7K
137.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
N/A
$0.90
Revenue Next Year
$638.39
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$20.23
$9.22
52 Week High
$39.71
$19.60

Technical Indicators

Market Signals
Indicator
ASMB
NPCE
Relative Strength Index (RSI) 62.24 52.22
Support Level $32.57 $13.75
Resistance Level $37.00 $15.27
Average True Range (ATR) 1.56 0.62
MACD 0.02 0.11
Stochastic Oscillator 65.20 64.66

Price Performance

Historical Comparison
ASMB
NPCE

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: